 | | NETWORK: N01556 | |
Entry |
|
Name |
IL6 family to Jak-STAT signaling pathway
|
Definition |
(IL6,IL11,IL13,IL27,IL31,OSM,LIF,CNTF,CTF1,CLCF1) -> ((IL6ST+(IL6R,IL11RA,IL27RA,OSMR,LIFR,CNTFR)),(IL4R+IL13RA),(IL31RA+OSMR)) -> (JAK1+JAK2+TYK2) -> (STAT1,STAT3,STAT6) |
Expanded |
(3569,3589,3596,246778,386653,5008,3976,1270,1489,23529) -> ((3572+(3570,3590,9466,9180,3977,1271)),(3566+3597+3598),(133396+9180)) -> (3716+3717+7297) -> (6772,6774,6778) |
Class |
|
Type |
Reference
|
Pathway |
|
Gene |
3589 | IL11; interleukin 11 |
3596 | IL13; interleukin 13 |
3976 | LIF; LIF interleukin 6 family cytokine |
1270 | CNTF; ciliary neurotrophic factor |
1489 | CTF1; cardiotrophin 1 |
23529 | CLCF1; cardiotrophin like cytokine factor 1 |
3572 | IL6ST; interleukin 6 cytokine family signal transducer |
3570 | IL6R; interleukin 6 receptor |
3590 | IL11RA; interleukin 11 receptor subunit alpha |
9466 | IL27RA; interleukin 27 receptor subunit alpha |
9180 | OSMR; oncostatin M receptor |
3977 | LIFR; LIF receptor subunit alpha |
1271 | CNTFR; ciliary neurotrophic factor receptor |
3566 | IL4R; interleukin 4 receptor |
3597 | IL13RA1; interleukin 13 receptor subunit alpha 1 |
3598 | IL13RA2; interleukin 13 receptor subunit alpha 2 |
133396 | IL31RA; interleukin 31 receptor A |
3716 | JAK1; Janus kinase 1 |
3717 | JAK2; Janus kinase 2 |
7297 | TYK2; tyrosine kinase 2 |
6772 | STAT1; signal transducer and activator of transcription 1 |
6774 | STAT3; signal transducer and activator of transcription 3 |
6778 | STAT6; signal transducer and activator of transcription 6 |
|
Reference |
|
Authors |
Morris R, Kershaw NJ, Babon JJ |
Title |
The molecular details of cytokine signaling via the JAK/STAT pathway. |
Journal |
|
Reference |
|
Authors |
Salas A, Hernandez-Rocha C, Duijvestein M, Faubion W, McGovern D, Vermeire S, Vetrano S, Vande Casteele N |
Title |
JAK-STAT pathway targeting for the treatment of inflammatory bowel disease. |
Journal |
|
Reference |
|
Authors |
Tzeng HT, Chyuan IT, Lai JH |
Title |
Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential. |
Journal |
|
LinkDB |
|
|
|